Sonoma Biotherapeutics

1 follower

‌

Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approac... Read more


Org chart

Jeff Bluestone
CEO & President
Collapse
Fred Ramsdell
Chief Scientific Officer
Jimmy Chung
Director, Information Technology
Melisa S. Medrano
Director Of Talent
Joe Arron
Chief Scientific Officer
Stacey Delaney
Senior Director, Total Rewards & People Operations
Anavelys Ortiz-Suarez
Head, Intellectual Property & Legal Operations
Katherine Galindo
Director Of Regulatory Affairs

Board & advisors

Toni Hoover
Board Member
Terry Rosen
Board Member
Maggie Wilderotter
Board Member
Frank Yu
Board Member
John C. Davis Jr.
Board Member
Katina Dorton
Board Member
John C Davis
Board Member